Fredrik Conradi Schreuder
Chairman at RespiNor AS
Fredrik Conradi Schreuder active positions
| Companies | Position | Start | End |
|---|---|---|---|
NeoRad AS
 NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Director/Board Member | - | - |
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Chairman | - | - |
| Director/Board Member | - | - |
Career history of Fredrik Conradi Schreuder
Former positions of Fredrik Conradi Schreuder
| Companies | Position | Start | End |
|---|---|---|---|
| ALGETA ASA | Chairman | - | - |
| Hafslund Nycomed AS | Corporate Officer/Principal | - | - |
Statistics
International
| Norway | 5 |
Operational
| Director/Board Member | 2 |
| Chairman | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
NeoRad AS
NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Health Technology |
| Hafslund Nycomed AS | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
RespiNor AS
RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
